At The Medicine Shoppe® Pharmacies, we are dedicated to providing products and services to care for your family’s wellness. One of those services is health news you can trust. Use the filters to focus on the information that is important to you, then bookmark this page to make it a regular stop anytime you’re online.
Silent Stroke Causes Found Among Sickle Cell Kids
Silent stroke may be the most common form of brain injury in children with sickle cell anemia, a rare, painful blood disorder. Recently, researchers have been able to pinpoint the risk factors for such strokes in children.
Stem Cells Age Too
Everything ages over time. And human stem cells are no exception. Understanding this aging process may help explain why the elderly are more susceptible to infections and certain cancers.
Expanding Chronic Myeloid Leukemia Options
Research into more effective treatments for chronic myeloid leukemia is opening up all sorts of possibilities. Drugs are being combined, new drugs are being developed and there is even work involving a possible vaccine.
Chronic Myeloid Leukemia Advancements
The outlook for people with chronic myeloid leukemia has improved by leaps and bounds in recent years. A number of medications are now keeping the disease under wraps.
Erwinaze Approved to Treat Leukemia
The U.S. Food and Drug Administration has approved Erwinaze ( asparaginase Erwinia chrysanthemi ) to treat patients with acute lymphoblastic leukemia (ALL), who have developed an allergy (hypersensitivity) to E. coli derived asparaginase and pegapargase chemotherapy drugs used to treat ALL.
Does Your Blood Type Indicate Stroke Risk?
Some individuals may be at a higher risk of stroke simply by nature of their blood type. Those with blood type AB may be at an increased risk of stroke regardless of other factors.
FDA Approves First Drug to Treat a Rare Bone Marrow Disease
The U.S. Food and Drug Administration today approved Jakafi ( ruxolitinib ), the first drug approved to specifically treat patients with the bone marrow disease myelofibrosis .
Hiding in Plain Sight - Old Drug, New Use
Finding new uses for existing drugs has taken on new emphasis of late. With advanced technology making it easier to test for "new" benefits in existing drugs, medical researchers may have hit a home run with an old antibiotic.
Apixaban Fails to Reduce Blood Clots
An experimental drug designed to aid severely ill patients after hospitalization is not more effective than standard treatments for reducing the risk of blood clots, a study has confirmed.
First Cord Blood Product Gets FDA Stamp of Approval
For the first time, U.S. Food and Drug Administration officials have given the green light to an umbilical cord blood product that could be used in stem cell transplants for patients with blood cancer, or metabolic or immune disorders.